ATE286137T1 - Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus - Google Patents

Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus

Info

Publication number
ATE286137T1
ATE286137T1 AT93902962T AT93902962T ATE286137T1 AT E286137 T1 ATE286137 T1 AT E286137T1 AT 93902962 T AT93902962 T AT 93902962T AT 93902962 T AT93902962 T AT 93902962T AT E286137 T1 ATE286137 T1 AT E286137T1
Authority
AT
Austria
Prior art keywords
virus
vaccine against
recombinant vaccinia
against marek
vaccinia virus
Prior art date
Application number
AT93902962T
Other languages
English (en)
Inventor
Enzo Paoletti
Jill Taylor
James Tartaglia
Louis Ross
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Application granted granted Critical
Publication of ATE286137T1 publication Critical patent/ATE286137T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT93902962T 1992-01-13 1993-01-07 Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus ATE286137T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82007792A 1992-01-13 1992-01-13
US139193A 1993-01-06 1993-01-06
PCT/US1993/000084 WO1993014219A1 (en) 1992-01-13 1993-01-07 Marek's disease virus recombinant poxvirus vaccine

Publications (1)

Publication Number Publication Date
ATE286137T1 true ATE286137T1 (de) 2005-01-15

Family

ID=26668976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902962T ATE286137T1 (de) 1992-01-13 1993-01-07 Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus

Country Status (10)

Country Link
EP (2) EP1489165A1 (de)
JP (1) JP3706130B2 (de)
AT (1) ATE286137T1 (de)
AU (1) AU680609B2 (de)
CA (1) CA2127700C (de)
DE (1) DE69333728T2 (de)
DK (1) DK0623172T3 (de)
ES (1) ES2236684T3 (de)
PT (1) PT623172E (de)
WO (1) WO1993014219A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
EP0696204A4 (de) * 1993-02-26 1999-03-31 Syntro Corp Rekombinierter geflügelpockenvirus und seine verwendung
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
ES2309996T3 (es) * 1996-03-29 2008-12-16 Zeon Corporation Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso.
GB2460694A (en) * 2008-06-06 2009-12-09 Secr Defence Attenuated poxviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
EP0284416B1 (de) * 1987-03-27 1995-02-22 Nippon Zeon Co., Ltd. Rekombinantes Avipoxvirus
DE10399032I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
JP2538367B2 (ja) * 1988-06-24 1996-09-25 ブリティッシュ・テクノロジー・グループ・リミテッド Ｆｏｗｌｐｏｘウィルスの非必須領域
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
BE1004877A3 (fr) * 1991-05-27 1993-02-16 Solvay Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.
CA2110489A1 (en) * 1991-06-14 1992-12-23 Enzo Paoletti Immunodeficiency virus recombinant poxvirus vaccine
US5369025A (en) * 1991-06-28 1994-11-29 The United States Of America As Represented By The Secretary Of Agriculture Recombinant fowlpox vaccine for protection against Marek's disease

Also Published As

Publication number Publication date
EP0623172A4 (de) 1995-08-09
EP0623172B1 (de) 2004-12-29
WO1993014219A1 (en) 1993-07-22
JPH07503843A (ja) 1995-04-27
DK0623172T3 (da) 2005-04-25
AU680609B2 (en) 1997-08-07
ES2236684T3 (es) 2005-07-16
EP1489165A1 (de) 2004-12-22
JP3706130B2 (ja) 2005-10-12
DE69333728D1 (de) 2005-02-03
PT623172E (pt) 2005-02-28
EP0623172A1 (de) 1994-11-09
CA2127700A1 (en) 1993-07-22
DE69333728T2 (de) 2006-08-31
CA2127700C (en) 2006-06-20
AU3435393A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
CA2014465A1 (en) Herpesvirus recombinant poxvirus vaccine
GB2269820A (en) Flavivirus recombinant poxvirus vaccine
DE4090351T1 (de) Rekombinantes Pockenvirus-Wirtsselektionssystem
DE68927025D1 (de) HIV-2-Virusvarianten
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
DE3853088D1 (de) Rekombinantes Avipoxvirus.
ATE229978T1 (de) Helicobacter proteine und impstoffe
DE3677494D1 (de) Virus-impfstoff.
DE59209921D1 (de) Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
ATE120489T1 (de) Rekombinante coccidiosis-vakzine.
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
ES2045475T3 (es) Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus.
DE69230627D1 (de) Rekombinantes Avipoxvirus
DE68920610D1 (de) Rekombinantes Virus der Marekschen Krankheit und Vakzin.
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
EP0662594A3 (de) Luftleitvorrichtung.
EP0956343A4 (de) Rekombinanter schweinepockenvirus
DE69333728D1 (de) Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
GB2264949A (en) Measles virus recombinant poxvirus vaccine
ATE233821T1 (de) Poxvirusvektoren und deren anwendung als impstoff gegen katzenansteckende peritonitis- viruskrankheit
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
DK498387D0 (da) Virus-dna-sekvens
RU1800124C (ru) Бытовой вентил тор
CA2259047A1 (en) Innoculation kits for avoiding maternal immunity
IT1228928B (it) Procedimento per l'ottenimento di un vaccino ricombinante contro l'epatite b.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0623172

Country of ref document: EP